Gemcitabine plus irinotecan as first-line weekly therapy in locally advanced and/or metastatic pancreatic cancer.

Neri, B; Cipriani, G; Grifoni, R; Molinara, E; Pantaleo, P; Rangan, S; Vannini, A; Tonelli, P; Valeri, A; Pantalone, D; Taddei, A; Bechi, P

Neri, B; Cipriani, G; Grifoni, R; Molinara, E; Pantaleo, P; Rangan, S; Vannini, A; Tonelli, P; Valeri, A; Pantalone, D; Taddei, A; Bechi, P.

Affiliation

Neri B; Department of Oncology, Centre of Experimental and Clinical Oncology, Florence University, AOU Careggi, Florence, Italy. bruno.neri@unifi.it

Oncol Res ; 17(11-12): 559-64, 2009.

Article in En | MEDLINE | ID: mdl-19806786

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Oncol Res Journal subject: NEOPLASIAS Year: 2009 Document type: Article Affiliation country: Italia Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links